Commercial Launch. Licensee shall give Schering prior written notice of at least sixty (60) days of its intent to file an NDA for the Licensed Product and at that time shall further provide Schering with the anticipated date of First Commercial Sale for the Licensed Product in the country of filing. Licensee shall promptly provide Schering with notice of any Regulatory Approval of Licensed Product.
Appears in 2 contracts
Sources: License Agreement (Eiger BioPharmaceuticals, Inc.), License Agreement (Celladon Corp)